Two vaccines combined to secure 460 million doses… German Health “Possibility to Start Next Week Delivery”
The European Union (EU) executive committee approved the conditional sale of a novel coronavirus infection (Corona 19) vaccine developed by the US pharmaceutical company Modena on the 6th (local time).
Accordingly, 27 EU member states with a population of 450 million will be able to use the second Corona 19 vaccine following a vaccine jointly developed by Pfizer, a US pharmaceutical company, and Bioentech, Germany.
The EU Commission made an official approval decision on the afternoon of the afternoon of just hours after the European Medicines Agency (EMA) recommended the conditional marketing of modders or vaccines.
Earlier that day, EMA recommended approval for the use of the vaccine for those over the age of 18 at an expert meeting.
The EU’s conditional marketing approval is a procedure to quickly respond to emergencies threatening public health such as COVID-19, allowing pharmaceuticals to be sold in 27 member states for one year and can be renewed annually.
According to the decision of the EU Commission on this day, each Member State can now begin vaccinating modders.
“We will supply more COVID-19 vaccines for Europeans,” said Urzula Ponderrayen, head of the EU administration, in a statement on the day. “With the second EU-approved vaccine, the Modena vaccine, we will further It will secure 160 million doses.”
The Modena vaccine will be available between the first and third quarters of this year, the EU Commission said.
German Health Minister Jens Sfan said today that he expects Modena vaccine to begin spreading to EU member states next week before the EMA announcement, the Associated Press said.
Bloomberg reported that Modena could start shipping within the next week, citing Secretary Spane.
Modena vaccine approval was criticized for the slow inoculation of the Pfizer-Bioentech vaccination, which started at the end of last month, and the EU has not secured sufficient vaccines early amid the continued spread of Corona 19 and growing concerns about the mutant virus in EU member states. It was achieved in the midst of rising.
The EU approved the conditional sale of the Pfizer-Bioentech vaccine for the first time on the 21st of last month, and the vaccination began in earnest from the 27th of the same month.
However, in the past week since vaccination began in the EU, there have been hundreds of thousands of Europeans who have been vaccinated, Reuters said.
In the UK, the number of first inoculations exceeded 1 million.
There is also a large difference in vaccination rates by member countries.
According to the Associated Press, France received 500 vaccines in the first week, while Germany received 200,000 vaccines.
The Netherlands was the last member nation to start vaccination on this day.
The United States, Canada and Israel have already approved Modena vaccines following Pfizer-Bioentech.
The EU Commissioner for Health Stella Kyriachides said that the combination of Pfizer-Bioentech vaccine and Moderna vaccine can now provide 460 million doses of vaccine in the EU.
The EU Commission previously signed a contract with Modena to purchase 160 million doses of vaccine and 300 million doses with Pfizer-Bioentech.
Reuters reported, citing a source that the EU is discussing with the company to purchase an additional 50 to 100 million doses of Pfizer-Bioentech vaccine.
Modena announced that the final analysis of its vaccine phase 3 clinical trial showed that it had 94.1% preventive effect, and applied for marketing approval to EMA on November 30 last year.
Like Pfizer-Bioentech, Modena vaccine was developed using’messenger ribonucleic acid’ (mRNA, messenger RNA) containing the genetic information of the virus. You can keep it.
/yunhap news